Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-060607
Filing Date
2021-10-15
Accepted
2021-10-15 17:15:24
Documents
1
Period of Report
2021-10-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1533
  Complete submission text file 0001209191-21-060607.txt   3180
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Issuer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address
Glickman Mark A (Reporting) CIK: 0001441461 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-00100 | Film No.: 211326722